How membrane proteins' sequences and movements control their function

Elucidating sequence, structural and dynamic basis of the functional regulation of membrane proteins

NIH-funded research University of Illinois at Urbana-Champaign · NIH-11191598

Researchers are building computer tools to predict how changes in membrane transporters and receptors alter their shape and behavior, which could help people with conditions linked to these proteins.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Urbana-Champaign NIH-funded
Lab location1 site (Champaign, United States)
Project IDNIH-11191598 on NIH RePORTER

What this research studies

This project combines computer modeling and laboratory mutation experiments to see how membrane proteins like monoamine transporters and Class C GPCRs change shape and function. The team will use transfer learning and molecular dynamics simulations together with deep mutagenesis data to map the effects of many different mutations. By matching lab-measured mutation effects with simulations, they aim to reveal the atomic-level steps these proteins take when they work or malfunction. The work is done at the University of Illinois and focuses on using computational tools to guide experiments and interpret results.

Who could benefit from this research

Good fit: People with neurological or psychiatric conditions linked to monoamine transporters, known genetic variants in transporters or Class C GPCRs, or those interested in donating genetic or cell-sample data for research would be most relevant.

Not a fit: Patients whose conditions are unrelated to membrane transporters or GPCRs, or those seeking immediate clinical therapies, are unlikely to see direct benefit from this basic research.

Why it matters

Potential benefit: If successful, the work could reveal how specific mutations change transporter and receptor behavior and point to new drug targets or more precise treatments.

How similar studies have performed: Related efforts combining deep mutagenesis and modeling have recently revealed active receptor structures, but using transfer learning to predict mutation effects across multiple transporter and GPCR families is a newer approach.

Where this research is happening

Champaign, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.